July 28, 2022 Comments Off on New patent for NOVO drug RYBELSUS Posted in: Patent Added Annual Drug Patent Expirations for RYBELSUS Rybelsus is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for NOVO drug RYBELSUS appeared first on DrugPatentWa…
July 28, 2022 Comments Off on Pharmaceutical companies with the most orphan drugs Posted in: Infographic Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…
